DCT

1:23-cv-00101

Novo Nordisk Inc v. Mylan Pharma Inc

General
Filed
01/27/23
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (L)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
40%